(Q37050053)

17 August 2017

1 reference

title

Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia (English)

1 reference

17 August 2017

0 references

Phyllis W Speiser

1

1 reference

17 August 2017

publication date

10 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

68 Suppl 5

1 reference

17 August 2017

page(s)

90-92

1 reference

Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology

17 August 2017

cites work

1 reference

Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.

21 January 2018

1 reference

Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls

21 January 2018

1 reference

Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia

21 January 2018

1 reference

Pitfall of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.

21 January 2018

1 reference

Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000110586

1 reference

17 August 2017

1 reference